MACQUARIE GROUP LTD - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,445
-19.7%
1,4730.0%0.00%
Q2 2023$14,259
+29.6%
1,473
+322.1%
0.00%
Q3 2022$11,000
-26.7%
349
-77.1%
0.00%
Q2 2022$15,000
-21.1%
1,5240.0%0.00%
Q1 2022$19,000
-84.7%
1,524
-71.8%
0.00%
Q4 2021$124,000
+376.9%
5,408
+360.3%
0.00%
Q3 2021$26,0001,1750.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders